Guidelines for the use of palivizumab in infants and young children with congenital heart disease
- 5 April 2006
- journal article
- practice guideline
- Published by Wiley in Pediatrics International
- Vol. 48 (2) , 190-193
- https://doi.org/10.1111/j.1442-200x.2006.02179.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus InfectionsPediatrics, 2003
- Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart diseaseThe Journal of Pediatrics, 2003
- Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac diseaseCardiology in the Young, 2003
- Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIVPediatrics, 1998
- Respiratory syncytial virus infection in children with congenital heart disease: A reviewPediatric Cardiology, 1996
- Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, JapanPediatrics International, 1993
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian childrenThe Journal of Pediatrics, 1992
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982